Zydus gets final nod from USFDA for Scopolamine Transdermal System 1 mg/3 days
This is the fifth ANDA approval for Zydus in the transdermal portfolio, leveraging the group’s strengths in the manufacturing of ...
Tag: Scopolamine Transdermal System
